BSE filing, NSE: BAMPSL. Summary written from the filing by ALFA Finder's alert engine.
Bampsl Securities Ltd: key numbers
- Share price
- ₹18.00
- Market cap
- ₹61.26 Cr
- Revenue (annual)
- ₹25.22 Cr
- Net profit (annual)
- ₹0.40 Cr
- P/E (TTM)
- 155.8×Sector 19.7×
- Promoter holding
- 10.83%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bampsl Securities Ltd
All →Bampsl Securities Annual General Meeting
Bampsl Securities Limited held its 31st Annual General Meeting, where it passed resolutions to adopt financial statements and re-appoint directors.
Bampsl Securities Annual Report
Bampsl Securities Ltd has released its 31st Annual Report for the 2025-2026 financial year. The company's Annual General Meeting is scheduled for September 29, 2026.
Bampsl Securities Board Meeting Outcome
Bampsl Securities Ltd approved the notice of the Annual General Meeting and appointed a scrutinizer in its board meeting held on August 25, 2026.
Bampsl Securities Board Meeting Date
Bampsl Securities Ltd has scheduled a Board Meeting on August 25, 2026, to discuss the Annual General Meeting notice, date, and appointment of scrutinizers.
Bampsl Securities Q1 FY27 Results: Net Profit ₹0.5 Cr, Up 0.0% YoY
Bampsl Securities Ltd reported revenue from operations of ₹3.6 Cr (-58.6% YoY) and net profit of ₹0.5 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.5 Cr · +0.0% YoY
Bampsl Securities Board Meeting Date
Bampsl Securities Limited will hold a board meeting on August 7, 2026. The meeting's agenda is to consider and approve the unaudited financial results.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.